Danie Ty, MD
Family Practice · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ty’s office at (415) 600-1020 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A120302 · Current
Licensed to practise in California · since 2018 · expires 2028-09-30 · Mcgill University Faculty of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$70,672
Medicare paid this office $70,672 for 421 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 204 | $24,489 | $114 |
| Long return visit (40+ min) | 97 | $16,106 | $163 |
| New patient visit (45+ min) | 42 | $5,898 | $140 |
| Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | 34 | $4,753 | $140 |
| Short return visit (20+ min) | 50 | $3,701 | $71 |
See all 15 services
| Return visit (30+ min) | 204 | $24,489 | $114 |
| Long return visit (40+ min) | 97 | $16,106 | $163 |
| New patient visit (45+ min) | 42 | $5,898 | $140 |
| Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | 34 | $4,753 | $140 |
| Short return visit (20+ min) | 50 | $3,701 | $71 |
| New patient visit (60+ min) | 17 | $3,444 | $203 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 13 | $1,219 | $68 |
| New patient visit (30+ min) | 22 | $1,106 | $50 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 12 | $603 | $50 |
| Short return visit | 11 | $562 | $51 |
| Injection of drug or substance into vein | 13 | $511 | $39 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 22 | $356 | $16 |
| Automated urinalysis test | 40 | $95 | $2 |
| Injection, ceftriaxone sodium, per 250 mg | 19 | $36 | None |
| Infusion, normal saline solution , 1000 cc | 14 | $31 | None |
Who their Medicare patients are
421 Original Medicare patients in 2024. Average age 78 · Women 61% · Also on Medicaid 6% · Health risk score 1.00. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 62% · Coronary heart disease 25% · Atrial fibrillation 21% · Cancer 18% · Diabetes 17% · Chronic kidney disease 17% · Depression 13% · Heart failure 10% · COPD 8% · Dementia 7% · Stroke 7%.
The office billed $250,745, Medicare allowed $95,031 and paid $70,672; for 1,851 services of 58 kinds; $251 of it was for drugs given in the office and $70,422 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 421 | 1,851 | 78 | 1.00 | $250,745 | $70,672 |
| 2023 | 410 | 1,538 | 78 | 0.96 | $188,510 | $55,290 |
| 2022 | 434 | 1,750 | 78 | 1.00 | $215,402 | $64,219 |
| 2021 | 415 | 3,055 | 79 | 0.97 | $208,173 | $62,270 |
| 2020 | 306 | 1,745 | 78 | 1.07 | $161,285 | $39,169 |
| 2019 | 141 | 318 | 78 | 1.01 | $67,932 | $21,016 |
| 2018 | 162 | 185 | 80 | 2.17 | $69,955 | $18,290 |
| 2017 | 508 | 605 | 78 | 2.34 | $220,601 | $56,544 |
| 2016 | 747 | 928 | 78 | 2.06 | $396,180 | $84,871 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 15 services
| Return visit (30+ min) | 144 | $16,959 | $115 |
| Short return visit (20+ min) | 164 | $13,948 | $81 |
| Long return visit (40+ min) | 32 | $5,152 | $156 |
| New patient visit (45+ min) | 27 | $4,163 | $154 |
| New patient visit (30+ min) | 36 | $3,134 | $87 |
| Wound closure utilizing tissue adhesive(s) only | 13 | $1,672 | $129 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 15 | $754 | $50 |
| Short return visit | 12 | $682 | $57 |
| Injection of drug or substance into vein | 12 | $485 | $40 |
| Diphtheria and tetanus vaccine (7 years or older) | 14 | $298 | $21 |
| Administration of vaccine | 14 | $277 | $20 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 12 | $194 | $16 |
| Injection of drug or substance under skin or into muscle | 11 | $173 | $14 |
| Automated urinalysis test | 46 | $101 | $2 |
| Injection, ceftriaxone sodium, per 250 mg | 18 | $41 | None |
2022: 13 services
| Return visit (30+ min) | 191 | $23,236 | $115 |
| Short return visit (20+ min) | 96 | $7,889 | $80 |
| New patient visit (45+ min) | 47 | $6,977 | $148 |
| Long return visit (40+ min) | 42 | $6,807 | $162 |
| New patient visit (30+ min) | 42 | $4,452 | $106 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 47 | $2,378 | $51 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 19 | $1,719 | $72 |
| Short return visit | 20 | $844 | $42 |
| Injection of drug or substance under skin or into muscle | 32 | $581 | $14 |
| Injection of drug or substance into vein | 12 | $509 | $42 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 12 | $195 | $16 |
| Automated urinalysis test | 49 | $111 | $2 |
| Injection, ceftriaxone sodium, per 250 mg | 23 | $47 | None |
2021: 15 services
| Return visit (30+ min) | 209 | $24,553 | $113 |
| Long return visit (40+ min) | 44 | $7,736 | $176 |
| New patient visit (45+ min) | 47 | $6,829 | $145 |
| Short return visit (20+ min) | 50 | $4,698 | $87 |
| New patient visit (30+ min) | 22 | $2,204 | $100 |
| New patient visit (60+ min) | 11 | $2,152 | $196 |
| Injection of drug or substance into vein | 27 | $1,525 | $45 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 23 | $1,231 | $51 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 11 | $955 | $80 |
| Short return visit | 16 | $849 | $53 |
| Infusion into a vein for hydration, 31-60 minutes | 14 | $542 | $39 |
| Injection of drug or substance under skin or into muscle | 21 | $301 | $14 |
| Automated urinalysis test | 53 | $119 | $2 |
| Injection, ceftriaxone sodium, per 250 mg | 28 | $64 | None |
| Infusion, normal saline solution , 1000 cc | 17 | $40 | None |
2020: 9 services
| Return visit (30+ min) | 212 | $20,701 | $89 |
| New patient visit (45+ min) | 41 | $4,688 | $114 |
| Short return visit (20+ min) | 36 | $2,170 | $60 |
| Injection of drug or substance into vein | 36 | $1,686 | $40 |
| Infusion into a vein for hydration, 31-60 minutes | 12 | $397 | $33 |
| Injection of drug or substance under skin or into muscle | 12 | $199 | $14 |
| Automated urinalysis test | 39 | $89 | $2 |
| Injection, ceftriaxone sodium, per 250 mg | 24 | $61 | None |
| Infusion, normal saline solution , 1000 cc | 14 | $26 | None |
2019: 4 services
| Return visit (30+ min) | 95 | $10,162 | $101 |
| New patient visit (45+ min) | 18 | $2,802 | $156 |
| Short return visit (20+ min) | 25 | $1,616 | $65 |
| Injection, ceftriaxone sodium, per 250 mg | 11 | $19 | None |
2018: 4 services
| Initial hospital observation care per day, typically 70 minutes | 36 | $5,966 | $166 |
| Hospital observation care on day of discharge | 72 | $4,840 | $65 |
| Initial hospital observation care per day, typically 30 minutes | 18 | $1,696 | $89 |
| Initial hospital observation care per day, typically 50 minutes | 13 | $1,575 | $121 |
2017: 12 services
| Initial hospital observation care per day, typically 70 minutes | 81 | $13,318 | $162 |
| Hospital observation care on day of discharge | 161 | $10,458 | $64 |
| Hospital discharge day management, 30 minutes or less | 74 | $4,836 | $64 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 35 | $4,268 | $122 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 37 | $4,167 | $93 |
| Initial hospital observation care per day, typically 50 minutes | 34 | $4,098 | $121 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 35 | $3,184 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,703 | $180 |
| Initial hospital observation care per day, typically 30 minutes | 27 | $2,485 | $89 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 32 | $2,301 | $64 |
| Follow-up observation care per day, typically 35 minutes | 12 | $1,043 | $87 |
| Follow-up observation care per day, typically 15 minutes | 14 | $534 | $36 |
2016: 9 services
| Hospital observation care on day of discharge | 422 | $28,058 | $64 |
| Initial hospital observation care per day, typically 70 minutes | 156 | $25,370 | $163 |
| Initial hospital observation care per day, typically 30 minutes | 136 | $12,046 | $87 |
| Follow-up observation care per day, typically 35 minutes | 52 | $4,914 | $93 |
| Initial hospital observation care per day, typically 50 minutes | 38 | $4,552 | $120 |
| Initial hospital care with same-day admission and discharge with high level of medical decision making, per day at least 85 minutes | 18 | $3,459 | $192 |
| Initial hospital care with same-day admission and discharge with straightforward or low level of medical decision making, per day at least 45 minutes | 22 | $2,609 | $119 |
| Follow-up observation care per day, typically 25 minutes | 29 | $1,890 | $63 |
| Follow-up observation care per day, typically 15 minutes | 27 | $987 | $35 |
Drugs they prescribed that Part D paid
$2,394
Pharmacies billed $2,394 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (11 of 328) in 2024. Above the middle of the specialty; the typical family practice clinician is at 2%.
293 generic and fewer than 11 brand-name prescriptions · $2,394 in drug cost · 137 antibiotic prescriptions to 117 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Cephalexin | 51 | $260 | $5 |
| Amoxicillin-Clavulanate Potass | 27 | $170 | $6 |
| Polymyxin B Sul-Trimethoprim | 13 | $112 | $9 |
| Fluticasone Propionate | 12 | $101 | $7 |
| Doxycycline Hyclate | 17 | $93 | $5 |
See all 8 drugs
| Cephalexin | 51 | $260 | $5 |
| Amoxicillin-Clavulanate Potass | 27 | $170 | $6 |
| Polymyxin B Sul-Trimethoprim | 13 | $112 | $9 |
| Fluticasone Propionate | 12 | $101 | $7 |
| Doxycycline Hyclate | 17 | $93 | $5 |
| Azithromycin | 14 | $90 | $6 |
| Prednisone | 24 | $71 | $3 |
| Paxlovid | 19 | $0 | $0 |
Year by year
| 2024 | 328 | 249 | 3% (11) | None | $2,394 |
| 2023 | 266 | 201 | 10% (27) | 7% | $5,798 |
| 2022 | 268 | 203 | 6% (15) | 11% | $8,402 |
| 2021 | 202 | 158 | 14% (29) | None | $4,549 |
| 2020 | 133 | 103 | 14% (18) | None | $2,624 |
| 2019 | 78 | 59 | None | 14% | $1,735 |
| 2017 | 25 | 21 | None | None | $1,071 |
| 2016 | 41 | 23 | None | None | $3,165 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Cephalexin | 49 | $422 | $9 |
| Fluticasone Propionate | 11 | $282 | $26 |
| Nitrofurantoin Mono-Macro | 13 | $206 | $16 |
| Doxycycline Hyclate | 11 | $175 | $16 |
| Paxlovid (Eua) | 17 | $167 | $10 |
| Amoxicillin-Clavulanate Potass | 17 | $144 | $8 |
2022: 6 drugs
| Cephalexin | 37 | $247 | $7 |
| Paxlovid (Eua) | 20 | $207 | $10 |
| Nitrofurantoin Mono-Macro | 16 | $204 | $13 |
| Fluticasone Propionate | 16 | $146 | $9 |
| Amoxicillin-Clavulanate Potass | 11 | $107 | $10 |
| Prednisone | 20 | $73 | $4 |
2021: 3 drugs
| Amoxicillin-Clavulanate Potass | 20 | $285 | $14 |
| Cephalexin | 37 | $208 | $6 |
| Hydrocodone-Acetaminophen | 17 | $74 | $4 |
2020: 2 drugs
| Cephalexin | 22 | $106 | $5 |
| Hydrocodone-Acetaminophen | 13 | $71 | $5 |
Professional record
- NPI
- 1336407402
- Licence
- CA A120302, CT 050758California A120302: Current · expires 2028-09-30
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2012-04-26
- NPI last updated
- 2025-06-06
- NPI record certified
- 2025-06-06
This is when the NPI record was last certified, not a medical board exam.